Nebraska Cancer Specialists

Academic/Hospital

Also known as: Nebraska Cancer Specialists | Nebraska Cancer Specialists Methodist Estabrook Cancer Center | Nebraska Cancer Specialists; Midwest Cancer Center-Legacy | Ralph Hauke

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Oct 1, 2006

Last known activity

Jun 30, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (11 distinct, 4 trials)

Phase 2 (10 own, 0 via acquisition)

fluorouracil
aldesleukin
hydrocortisone
Filgrastim
pembrolizumab
leucovorin
docetaxel
cisplatin
sargramostim
dexamethasone

Phase 1 (1 own, 0 via acquisition)

testosterone

Indications

Studied for

Adenocarcinoma
Breast Neoplasms
Dyspareunia
Esophageal Neoplasms
Melanoma
Stomach Neoplasms

Recent trials (6)

NCT04329728OfficialPhase 1/Phase 2Jun 30, 2020
NCT03476174Overall official - principal investigatorPhase 2May 7, 2018
NCT03476174CollaboratorPhase 2May 7, 2018
NCT03476174Lead sponsorPhase 2May 7, 2018
NCT01697345Study directorEarly Phase 1Feb 1, 2013
NCT00515411CollaboratorPhase 2Oct 1, 2006

Details

Last known activity: Jun 30, 2020